Decrease in sirolimus-induced proteinuria after switch to everolimus in a liver transplant recipient with diabetic nephropathy.
Neau-Cransac
Martine
M
Moreau
Karine
K
Deminière
Colette
C
Merville
Pierre
P
Saric
Jean
J
D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D000068338:Everolimus; D006801:Humans; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011507:Proteinuria / Q000139:chemically induced / Q000188:drug therapy*; D020123:Sirolimus / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000068338:Everolimus; D020123:Sirolimus